Table 2. Clinical and demographic characteristics of the subgroups of patients based on their HoNOS trajectories.
HoNOS subgroups | Total number of patients | Psychotic disorder | Mood disorder | Substance- use disorder | Anxiety disorder | Personality disorder | Number of diagnoses | Gender | Age | Quality of life (baseline) | CANSAS (baseline) |
---|---|---|---|---|---|---|---|---|---|---|---|
N | N (%) | N (%) | N (%) | N (%) | N (%) | Median number of diagnoses (IQR) | Male (%) | Years (SD) | Total score (SD) | Median number of unmet needs (IQR) | |
Stable at a low problem- severity level | 709 | 512 (72%) | 147 (21%) | 126 (18%) | 68 (10%) | 79 (11%) | 1 (1–2) | 423 (60%) | 42.9 (11.1) | 37.8 (6.2) | 2 (1–4) |
Stable at a low medium problem-severity level | 1208 | 775 (64%) | 270 (22%) | 273 (23%) | 212 (18%) | 198 (16%) | 2 (1–2) | 693 (57%) | 43.3 (10.6) | 33.4 (7.3) | 4 (2–7) |
Stable at a high medium problem-severity level | 528 | 318 (60%) | 129 (24%) | 156 (30%) | 115 (22%) | 96 (18%) | 2 (1–3) | 331 (63%) | 43 (10.7) | 29.3 (7.6) | 6 (3–9) |
Stable at a high problem- severity level | 116 | 66 (57%) | 27 (23%) | 43 (37%) | 35 (30%) | 23 (20%) | 2 (1–3) | 77 (66%) | 44 (9.8) | 26.3 (7.7) | 9 (6–12) |
Ameliorating subgroup | 42 | 25 (60%) | 13 (31%) | 9 (21%) | 9 (21%) | 7 (17%) | 2 (1–2) | 25 (60%) | 41.8 (10.6) | 27.5 (5.4) | 7 (4–11) |
Deteriorating subgroup | 57 | 33 (58%) | 18 (32%) | 26 (46%) | 11 (19%) | 14 (25%) | 2 (1–3) | 40 (70%) | 46.3 (10.6) | 33.2 (9.2) | 4 (2–6) |
Total | 2660 | 1729 (65%) | 604 (23%) | 633 (24%) | 450 (17%) | 417 (16%) | 2 (1–2) | 1589 (60%) | 43.2 (10.7) | 33.5 (7.8) | 4 (2–7) |
Statistical test | chi2 = 27.053, df = 5, p < .001* | chi2 = 6.67, df = 5, p = .239* | chi2 = 51.131, df = 5, p < .001* | chi2 = 51.642, df = 5, p < .001* | chi2 = 18.946, df = 5, p = .002* | chi2 = 101.871, df = 5, p < .001 | chi2 = 9.446, df = 5, p = .093* | F = 1.379, df = 5, p.229** | F = 93.005, df = 5; 161.543 p < .001*** | chi2 = 381.857, df = 5, p < .001**** |
* Pearson's chi2 test
** One-way ANOVA
*** Welch's ANOVA
**** Kruskal Wallis test